Therefore, these data suggest that CTSD, DDIT4, MT1X, and SERPINE1 represent a set of relevant targets that could be further evaluated as biomarkers and/or gene targets to for breast cancer anti-metastasis therapeutics. This evidence concerns the gene SERPINE1 and breast carcinoma.